A comparison study of Optical Coherence Tomography Angiography Peripapillary Vessel Density in Early Glaucomatous and Normal Nigerian Eyes
NMJ · 2025-11-05
DOI: 10.71480/nmj.v67i2.1107 ↗At a glance
Journal article in NMJ, published on 2025-11-05. Written by Godswill Inye Nathaniel and 3 co-authors.
Abstract (original language)
Background: This study aimed to determine and compare the peripapillary vessel density (VD) in normal and early glaucomatous Nigerian eyes using Optical Coherence Tomography Angiography (OCTA), to provide evidence for the use of OCTA in enhancing the early diagnosis of glaucoma in Nigeria. Methodology: This was a hospital-based cross-sectional comparative study of 90 early glaucomatous participants and 90 normal participants. Participants aged 40 and above, with open anterior chamber angles (Schaffer’s) on gonioscopy, vertical cup disc ratio (VCDR)>0.4 and Central Visual Field (CVF) Mean deviation (MD) less than -6 dB, with glaucoma hemifield test (GHT) outside normal limits on a reliable 24-2 perimetry (Humphrey Field analyser II, Zeiss Humphrey Matrix 715) were recruited as early glaucomatous while aged matched control with vertical cup disc ratio
Subjects
Cite
APA
Nathaniel, G. I., Umeh, V., Ogunro, A., & Ogbonnaya, C. (2025). A comparison study of Optical Coherence Tomography Angiography Peripapillary Vessel Density in Early Glaucomatous and Normal Nigerian Eyes. NMJ. https://doi.org/10.71480/nmj.v67i2.1107
Vancouver
Nathaniel GI, Umeh V, Ogunro A, Ogbonnaya C. A comparison study of Optical Coherence Tomography Angiography Peripapillary Vessel Density in Early Glaucomatous and Normal Nigerian Eyes. NMJ. 2025. doi:10.71480/nmj.v67i2.1107
BibTeX
@article{Nathaniel2025,
author = {Nathaniel, Godswill Inye and Umeh, VictorChukwuebuka and Ogunro, Adunola and Ogbonnaya, Chimdia},
title = {A comparison study of Optical Coherence Tomography Angiography Peripapillary Vessel Density in Early Glaucomatous and Normal Nigerian Eyes},
journal = {NMJ},
year = {2025},
doi = {10.71480/nmj.v67i2.1107}
}
EUVIMED